Navigation Links
Metamark Genetics Board of Directors Appoints Shawn M. Marcell President and Chief Executive Officer
Date:4/30/2013

CAMBRIDGE, Mass., April 30, 2013 /PRNewswire/ -- Metamark Genetics, Inc., a leader in the discovery of novel molecular prognostic and diagnostic tests for cancer, today announced that industry veteran Shawn M. Marcell has been named the company's new president and chief executive officer. Mr. Marcell succeeds interim executive Michael Kauffman , M.D., who will remain on Metamark's board of directors. 

Metamark lead director Gregory C. Critchfield , M.D., said, "We are excited to welcome Shawn to Metamark as the company prepares to launch its first prognostic test, for prostate cancer. Shawn's broad and deep experience in life sciences, and his success in bringing innovative products to market, make him the ideal leader for Metamark as it grows into to a commercial organization."  Dr. Critchfield added, "We also would like to thank Michael Kauffman for his leadership during this important time in the company's evolution."

"Metamark's strategy to develop novel prognostic and diagnostic tests based on advanced quantitative histologic analysis has the potential to transform approaches to cancer and other major diseases," said Mr. Marcell. "I am thrilled to join the company and look forward to working with the entire team as we build a leading commercial stage molecular diagnostics company."

Mr. Marcell has nearly three decades of diverse executive, commercial and operational experience in life science and technology businesses. Most recently, he was the lead executive, serving as general manager of Hologic's (HOLX) wholly owned LIFECODES subsidiary, which was acquired by Immucor. He headed commercial operations at Sequenom (SQNM), which acquired SensiGen, where he served as president and CEO. Mr. Marcell has both CLIA laboratory and product launch experience and has had additional key management roles with Redpoint Bio, Prima Facie, Centocor and Abbott Diagnostics.

Mr. Marcell has been adjunct faculty and lecturer in Entrepreneurial Programs at the Wharton School and has served on numerous for-profit and non-profit boards.

About Metamark

Metamark Genetics is a privately held biotechnology company founded in 2007 to develop new function- based prognostic and diagnostic tests aimed at improving cancer care. The company's proprietary genomic and proteomic discovery platforms have yielded significant discoveries in several disease areas, including prostate, colon and breast cancers. During 2013, Metamark plans to commercialize ProMarkTM – its lead prostate cancer prognostic test – through its Cambridge, MA CLIA-certified laboratory.  For more information, please visit the company's Website at www.metamarkgenetics.com.

MetamarkTM and ProMarkTM are trademarks of Metamark Genetics, Inc.

 

 

 


'/>"/>
SOURCE Metamark Genetics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Intermountain Healthcare and Myriad Genetics Enter Into Research Collaboration Agreement
2. Genelex Receives First Patent on Business Methods for Pharmacogenetics
3. Response Genetics, Inc. to Release Second Quarter Financial Results and Host Conference Call on August 14, 2012
4. Epigenetics R&D Pipeline - Histone Deacetylases (HDACs) Offer the Most Promising Targets and Outnumber Other Classes of Epigenetic Targets
5. Millennium Laboratories Announces Landmark Pharmacogenetics Clinical Outcomes Study
6. The International Serious Adverse Event Consortium and UC San Diego To Collaborate On Research Into The Genetics Of Drug Induced Renal Injury
7. Submit Questions to Nobel Laureates and Other Experts about Genetics and Society
8. Amgen to Acquire deCODE Genetics, a Global Leader in Human Genetics
9. Clinical Data from NewLink Genetics HyperAcute Prostate Cancer Immunotherapy Published in Journal of Immunotherapy
10. Epigenetics Technology Market (Epigenomics, DNA Methylation, Histone Modifications, RNA Interference, Cancer Therapeutics, Personalized Medicine) (2012 - 2017)
11. NewLink Genetics Corporation Announces Proposed Public Offering of Common Stock
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/5/2016)... , Feb. 5, 2016 ... addition of the "Global Obstetrics Partnering ... company profile to their offering. --> ... of the "Global Obstetrics Partnering 2010-2016: ... profile to their offering. --> ...
(Date:2/4/2016)... , Feb. 4, 2016  Edwards Lifesciences Corporation (NYSE: ... for structural heart disease and critical care monitoring, announced ... repurchase (ASR) agreement with Morgan Stanley & Co. LLC ... repurchase is part of the Company,s previously authorized program ... common stock.  --> ...
(Date:2/4/2016)... 4, 2016 Worldwide Radiology Oncology surgical ... as next generation systems provide a way to ... cancer surgery. New systems pinpoint the delivery of ... been such a problem previously, limiting the quantity ... take cancer surgery far beyond what has been ...
Breaking Medicine Technology:
(Date:2/5/2016)... ... February 05, 2016 , ... ... stage for new clinical and scientific initiatives have all marked the last 12 ... appointed President and CEO of the nation’s oldest cancer center, Candace S. Johnson, ...
(Date:2/5/2016)... ... February 05, 2016 , ... The Muscular Dystrophy Association ... restaurants, launched the 14th annual “Appetite for a Cure” campaign on Feb. 1 ... ALS and related diseases that severely limit strength and mobility. , Now ...
(Date:2/5/2016)... (PRWEB) , ... February 05, 2016 , ... Looking for ... may be at the tips of your toes. Foot massage, whether administered by a ... pure comfort and relaxation. The American Board of Multiple Specialties in Podiatry ...
(Date:2/5/2016)... ... 2016 , ... After years as an active staff surgeon and having served ... Dr. Wayne Carman transitioned to chief of the Division of Plastic Surgery at what ... as chief and began a second three-year term in January of 2016. , The ...
(Date:2/5/2016)... ... February 05, 2016 , ... US Sports Camps , official operators of ... direct high-performance kids yoga training. ChildLight Yoga Studio is centrally situated in the picturesque ... , ChildLight Yoga Studio founder Lisa Flynn expresses her excitement, “We are thrilled to ...
Breaking Medicine News(10 mins):